MapLight Therapeutics, Inc. (MPLT) vs Tilray Brands, Inc. (TLRY)
A side-by-side comparison of MapLight Therapeutics, Inc. and Tilray Brands, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MPLT
MapLight Therapeutics, Inc.
$9.72HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT
TLRY
Tilray Brands, Inc.
$3.82HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT
Total return — MPLT vs TLRY
growth of $100 · dividends reinvested · last 1yMPLT -49.4% (-49.4%/yr)TLRY -75.0% (-75.0%/yr)MPLT compounded faster over this window
MPLT TLRY
MPLT vs TLRY: by the numbers
- •TLRY is the larger company ($427M vs $412M market cap).
- •Both run net losses; MPLT's is the smaller (0.00% vs -12.90% net margin).
Metrics side by side
Valuation
| Metric | MPLT | TLRY |
|---|---|---|
| P/S ratio | N/A | 0.37 |
| P/B ratio | 1.18 | 0.26 |
| EV / EBITDA | N/A | 23.04 |
Profitability
| Metric | MPLT | TLRY |
|---|---|---|
| Gross margin | 0.00% | 27.57% |
| Operating margin | 0.00% | -5.18% |
| Net margin | 0.00% | -12.90% |
| ROE | -65.99% | -9.23% |
| ROIC | -69.35% | -2.98% |
Growth (annualized)
| Metric | MPLT | TLRY |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 17.11% |
| Total return CAGR (5Y) | N/A | -49.30% |
Go deeper
Dig into the metrics
MapLight Therapeutics ROETilray Brands ROEMapLight Therapeutics operating marginTilray Brands operating marginMapLight Therapeutics revenue growthTilray Brands revenue growthMapLight Therapeutics free cash flowTilray Brands free cash flow
MapLight Therapeutics & Tilray Brands appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.